Literature DB >> 4083912

Controlled exposure of volunteers with chronic obstructive pulmonary disease to nitrogen dioxide.

W S Linn, D A Shamoo, C E Spier, L M Valencia, U T Anzar, T G Venet, E L Avol, J D Hackney.   

Abstract

Twenty-two volunteers with chronic obstructive pulmonary disease were exposed to nitrogen dioxide at 0.0, 0.5, 1.0, and 2.0 ppm in a controlled environment chamber. Exposure lasted 1 hr and included two 15-min exercise periods, during which the mean ventilation rate was roughly 16 L/min. Pulmonary mechanical function was evaluated pre-exposure, after initial exercise, and at the end of exposure. Blood oxygenation was measured by ear oximetry pre-exposure and during the second exposure period. Symptoms were recorded during exposures and for 1-wk periods afterward. No statistically significant changes in symptom reporting could be attributed to nitrogen dioxide exposure at any concentration, compared to the 0.0 ppm control condition. Measures of pulmonary mechanics showed either no significant changes, or small and equivocal changes. Arterial oxygen saturation showed marginal improvement with exercise, regardless of nitrogen dioxide concentration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4083912     DOI: 10.1080/00039896.1985.10545939

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  2 in total

1.  Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting.

Authors:  D G Markhorst; T Leenhoven; J W Uiterwijk; J Meulenbelt; A J van Vught
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

2.  Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease.

Authors:  Kristijan Bogdanovski; Trisha Chau; Chevalia J Robinson; Sandra D MacDonald; Ann M Peterson; Christine M Mashek; Windy A Wallin; Mark Rimkus; Frederick Montgomery; Joas Lucas da Silva; Shashank Gupta; Abdi Ghaffari; Adrian M Zelazny; Kenneth N Olivier
Journal:  Access Microbiol       Date:  2020-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.